990-91-0Relevant articles and documents
COMPOSITIONS AND METHODS FOR DETECTION OF TRAUMATIC BRAIN INJURY
-
, (2021/12/03)
The present disclosure relates generally to compositions and methods for determining whether a patient suffers from a traumatic brain injury (TBI) by detecting the presence of an amyloid beta protein in an eye of the patient. Also provided are compositions and methods for preparing a patient for diagnosis and treatment of traumatic brain injury (TB).
A oxazolidinone compounds of preparation method (by machine translation)
-
Paragraph 0042; 0043, (2017/05/12)
The invention provides a oxazolidinone compounds of the preparation method. Specifically provides the type 1 compound preparation method. The formula 1 compound preparation method comprises, formula 2 N - methyl - D - grape amine compound in the presence of a catalytic reduction, direct formula 1 compound. The present invention provides a preparation has simplified the reaction step, shorten the reaction route, can make the final yield of the product is higher, and, better purity. (by machine translation)
PROCESS FOR [3-[3(R)-[(R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]HOXY]-3(S)-(4-FLUOROPHENYL)MORPHOLIN-4-YL-5-OxO-4,5-DIHYDRO-[1,2,4]-TRIAZOL-1-YL PHOSPHONIC ACID
-
Page/Page column 5, (2008/06/13)
The present invention is concerned with a process for the preparation of the compound {3-[2(R)-[(1R)-1-[3,5-bis(tri-fluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid, and pharmaceutically acceptable salts thereof. This compound is useful as a substance P (neurokinin-1) receptor antagonist. In particular, the compound is useful e.g., in the treatment of emesis and inflammatory diseases.